APNA Scientific Partnership Award: Tom Insel, Director of NIMH

The APNA Scientific Partnership Award is administered by the APNA Board of Directors. It was established in 2012 to honor those interdisciplinary colleagues who have made significant contributions to the advancement of psychiatric nurses’ scientific knowledge. 

APNA is honored to present Thomas R. Insel, M.D., Director of the National Institute of Mental Health with the first Scientific Partnership Award. The award honors the partnership that the National Institute of Mental Health (NIMH) has afforded APNA in recent years. Under Dr. Insel’s leadership as NIMH Director, the Intramural Research Program has provided distinguished speakers for APNA conferences since 2009:

  • 2009
    • Daniel Weinberger, MD: Neurobiological and Genetic Mechanisms of Schizophrenia
  • 2010
    • Bruce Cuthbert, PhD: The NIMH Research Domain Criteria Project
    • Lisa Horowitz, PhD, M.P.H.: Detecting Suicidality in a Medical Setting
    • Maryland Pao, MD: Psychopharmacologic Transitions: From Adolescence to Adulthood
    • Sarah Spense, MD: Autism: It’s Not Just One Thing Anymore…Searching for Meaningful Subtypes
    • Carlos Zarate, MD: Emerging Somatic Treatments and Research Directions in Treatment-Resistant Depression
    • Carlos Zarate, MD: Overview of the Pharmacology of Suicide (presented for Ross Baldessarini, M.D.: due to illness)
  • 2012
    • Jose Apud, MD, PhD: Tardive Dyskinesia: What We Know and What We Need to Know
    • J. J. Rasimus, MD, PhD: First Do No Harm, But…Toxicology Lessons in Psychopharmacology   
  • 2013
    • Thomas R. Insel, MD: Disruptive Innovations in Clinical Neuroscience: Where Will We Find the Next Generation of Therapeutics?
    • Ellen Leibenluft, MD: Bipolar Disorder and Severe Irritability in Youth: Diagnosis and Treatment
    • Philip Shaw, MD, PhD: ADHD Across the Lifespan: Biologic Components and Contemporary Issues of Clinical Management

We thank Dr. Insel for his scientific leadership and we honor him as an APNA 2013 Clinical Psychopharmacology Institute Keynote Speaker.  Dr. Insel’s recent article, Translating Scientific Opportunity Into Public Health Impact: A Strategic Plan for Research on Mental Illness, in the Archives of General Psychiatry and his editorial A Bridge to Somewhere in the first edition of the 2011 journal Translational Psychiatry describe the interrelated issues of bench-to-bedside research, clinical lab research application to practice and how clinical practice requires supportive public health policy. We look forward to future collaborations between the National Institute of Mental Health and the American Psychiatric Nurses Association.